1-5 of 5
Andrea M. Perdue, PA-C
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Precision Medicine Approach Incorporating Both Molecular and In Vitro Functional Data to Treat Patients with Relapsed/Refractory Acute Myeloid Leukemia

Pamela S. Becker, MD PhD, Sylvia Chien, Timothy J Martins, PhD, Andrew Herstein, MD, Cody Hammer, Taylor Sekizaki, Vivian Oehler, MD, C. Anthony Blau, MD, Bradley A Patay, MD, Andrew Carson, PhD, Paul C. Hendrie, MD PhD, Roland B. Walter, MD PhD, Mary-Elizabeth M. Percival, MD MS, Soheil Meschinchi, MD PhD, Katherine Tarlock, MD, Ryan D Cassaday, MD, Kelda Gardner, PA-C, MHS, Heather Smith, PA-C, Andrea M. Perdue, PA-C, Frederick R. Appelbaum, MD, Jerald P. Radich, MD, Elihu H. Estey, MD
Journal: Blood
Blood (2016) 128 (22): 4043.
https://doi.org/10.1182/blood.V128.22.4043.4043
Published: 2016
Journal Articles

Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS): Final Results from a Phase 1/2 Study

Anna B. Halpern, MD, Sarah A. Buckley, MD, Megan Othus, PhD, Emily M Huebner, Kaysey F. Orlowski, Bart L Scott, MD, Andrea M. Perdue, PA-C, Heather A. Smith, PA-C, Pamela S. Becker, MD PhD, Paul C. Hendrie, MD PhD, Stephanie Cassone, MSN, FNP-BC, Tara L. Chen, PharmD, BCOP, Derek L. Stirewalt, Elihu H. Estey, MD, Roland B. Walter, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1064.
https://doi.org/10.1182/blood.V128.22.1064.1064
Published: 2016
Journal Articles

A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Anna B. Halpern, MD, Megan Othus, PhD, Emily M Huebner, Kaysey F. Orlowski, Bart L. Scott, MD, Heather A. Smith, PA-C, Pamela S. Becker, MD PhD, Mary-Elizabeth M. Percival, MD, Paul C. Hendrie, MD PhD, Andrea M. Perdue, PA-C, Tara L. Chen, PharmD, BCOP, Sarah A. Buckley, MD, Harry P. Erba, MD PhD, Elihu H. Estey, MD, Roland B. Walter, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1068.
https://doi.org/10.1182/blood.V128.22.1068.1068
Published: 2016
Journal Articles

Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly AML or High Risk MDS Patients

Kelda Gardner, PA-C, MHS, Elihu H. Estey, MD, Weigang Tong, MD, Robert McCroskey, MD, Roland B. Walter, MD PhD MS, Paul C. Hendrie, MD PhD, Bart L. Scott, MD MS, Andrea M. Perdue, PA-C, Mary-Elizabeth M. Percival, MD MS, Heather A. Smith, PA-C, Cody Hammer, Pamela S. Becker, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5207.
https://doi.org/10.1182/blood.V128.22.5207.5207
Published: 2016
Journal Articles

Phase 1 Trial of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)

Asma Anwar, MD, Anna B. Halpern, MD, Megan Othus, PhD, Bart L. Scott, MD, Paul C. Hendrie, MD PhD, Pamela S. Becker, MD PhD, Andrea M. Perdue, PA-C, Heather A. Smith, PA-C, Tara L. Chen, PharmD, Sarah A. Buckley, MD, Kaysey F. Orlowski, Morgan A. Powell, BS, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS
Journal: Blood
Blood (2015) 126 (23): 1339.
https://doi.org/10.1182/blood.V126.23.1339.1339
Published: 2015